BioSpace News Archive

Press Releases

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

March 16, 2026
·
7 min read
Press Releases

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

March 16, 2026
·
8 min read
Press Releases

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

March 16, 2026
·
9 min read
Press Releases

Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

March 16, 2026
·
12 min read
Press Releases

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

March 16, 2026
·
11 min read
Press Releases

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

March 16, 2026
·
9 min read
Press Releases

Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases

March 16, 2026
·
5 min read
Press Releases

George Medicines extends global commercialization of GMRx2 into Australia and New Zealand with Arrotex licensing agreement

March 16, 2026
·
7 min read
Press Releases

Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth

March 16, 2026
·
15 min read
Press Releases

Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

March 16, 2026
·
13 min read